Fibromyalgia
Fibromyalgia syndrome (FS) is a non-articular rheumatic disease, clinically manifested by multiple pains and stiffness in the musculoskeletal system, with tender points in specific locations. FS can be secondary to trauma, various rheumatic diseases, such as osteoarthritis, rheumatoid arthritis, and various non-rheumatic diseases (such as hypothyroidism, malignant tumors), etc. This type of FS is called secondary FS. If it is not accompanied by other diseases, it is called primary FS.
-
Site of disease:
muscle -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Myalgia muscle tenderness muscle spasm pain fatigue muscle soreness -
Concurrent disease:
Related Drugs
LYRICA- pregabalin_capsule
Indication: LYRICA is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury LYRICA is indicated for: 1 1 1 1 1.
Manufacturer:
LYRICA- pregabalin_solution
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 Postherpetic neuralgia (PHN) ( 1 Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 Fibromyalgia ( 1 Neuropathic pain associated with spinal cord injury ( 1.
Manufacturer:
Creekwood Pharmaceuticals LLC
DULOXETINE- duloxetine_capsule, delayed release
Indication: Duloxetine delayed-release capsule is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 Diabetic peripheral neuropathic Pain (DPNP) in adults ( 1 Fibromyalgia (FM) in adults ( 1 1 Chronic musculoskeletal pain in adults ( 1 Duloxetine delayed-release capsules are indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults and pediatric patients 13 years of age and older Chronic musculoskeletal pain in adults.
Manufacturer:
REMEDYREPACK INC.
DULOXETINE _DELAYED-RELEASE- duloxetine hydrochloride_capsule, delayed release pellets
Indication: Duloxetine delayed-release capsules is indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults and pediatric patients 13 years of age and older Chronic musculoskeletal pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 Diabetic peripheral neuropathic pain (DPNP) in adults ( 1 Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older ( 1 Chronic musculoskeletal pain in adults ( 1.
Manufacturer:
A-S Medication Solutions
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsule is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older (1) Fibromyalgia (1) Neuropathic pain associated with spinal cord injury (1).
Manufacturer:
REMEDYREPACK INC.
DULOXETINE_- duloxetine_capsule, delayed release
Indication: Duloxetine delayed-release capsules are indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults and pediatric patients 13 years of age and older Chronic musculoskeletal pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 Diabetic peripheral neuropathic pain (DPNP) in adults ( 1 Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older ( 1 Chronic musculoskeletal pain in adults ( 1.
Manufacturer:
Quallent Pharmaceuticals Health LLC
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN). (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older. (1) Fibromyalgia (1) Neuropathic pain associated with spinal cord injury.
Manufacturer:
REMEDYREPACK INC.
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsule is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older (1) Fibromyalgia (1) Neuropathic pain associated with spinal cord injury (1).
Manufacturer:
REMEDYREPACK INC.
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsule is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older (1) Fibromyalgia (1) Neuropathic pain associated with spinal cord injury (1).
Manufacturer:
REMEDYREPACK INC.
PREGABALIN- pregabalin_capsule
Indication: Pregabalin capsule is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsule is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older (1) Fibromyalgia (1) Neuropathic pain associated with spinal cord injury (1).
Manufacturer:
REMEDYREPACK INC.